SEC 13F Intelligence

Artia Global Partners LP / VRNA

Artia Global Partners LP’s Verona Pharma PLC Position

Does Artia Global Partners LP own Verona Pharma PLC (VRNA)? Not currently — the last reported position was 379.0K shares worth $40M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$40M
Q3 2025
Shares
379.0K
% of Portfolio
+6.41%
Quarters Held
10
position exited

Position History VRNA

Reported value by quarter
Q4 ’22: $1MQ4 ’22Q1 ’23: $2MQ4 ’23: $3MQ4 ’23Q1 ’24: $2MQ2 ’24: $2MQ2 ’24Q3 ’24: $4MQ4 ’24: $12MQ4 ’24Q1 ’25: $34MQ2 ’25: $87MQ2 ’25Q3 ’25: $40Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025379.0K$40M+6.41%
Q2 2025924.2K$87M+21.03%
Q1 2025538.5K$34M+8.65%
Q4 2024255.3K$12M+4.24%
Q3 2024148.6K$4M+1.17%
Q2 2024130.8K$2M+0.37%
Q1 2024130.8K$2M+0.42%
Q4 2023130.8K$3M+0.76%
Q1 202390.5K$2M+0.67%
Q4 202240.0K$1M+0.40%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artia Global Partners LP’s full portfolio or all institutional holders of VRNA.